2-31525043-T-TAA
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_000348.4(SRD5A2):c.*1151_*1152dupTT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00478 in 190,274 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0016 ( 2 hom., cov: 32)
Exomes 𝑓: 0.014 ( 0 hom. )
Consequence
SRD5A2
NM_000348.4 3_prime_UTR
NM_000348.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.414
Genes affected
SRD5A2 (HGNC:11285): (steroid 5 alpha-reductase 2) This gene encodes a microsomal protein expressed at high levels in androgen-sensitive tissues such as the prostate. The encoded protein is active at acidic pH and is sensitive to the 4-azasteroid inhibitor finasteride. Deficiencies in this gene can result in male pseudohermaphroditism, specifically pseudovaginal perineoscrotal hypospadias (PPSH). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0016 (226/141308) while in subpopulation SAS AF = 0.0435 (193/4438). AF 95% confidence interval is 0.0385. There are 2 homozygotes in GnomAd4. There are 163 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRD5A2 | NM_000348.4 | c.*1151_*1152dupTT | 3_prime_UTR_variant | Exon 5 of 5 | ENST00000622030.2 | NP_000339.2 | ||
SRD5A2 | XM_011533069.3 | c.*1151_*1152dupTT | 3_prime_UTR_variant | Exon 5 of 5 | XP_011531371.1 | |||
SRD5A2 | XM_011533072.3 | c.*1151_*1152dupTT | 3_prime_UTR_variant | Exon 7 of 7 | XP_011531374.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00162 AC: 229AN: 141262Hom.: 2 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
229
AN:
141262
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0140 AC: 684AN: 48966Hom.: 0 Cov.: 0 AF XY: 0.0132 AC XY: 299AN XY: 22714 show subpopulations
GnomAD4 exome
AF:
AC:
684
AN:
48966
Hom.:
Cov.:
0
AF XY:
AC XY:
299
AN XY:
22714
Gnomad4 AFR exome
AF:
AC:
34
AN:
2168
Gnomad4 AMR exome
AF:
AC:
30
AN:
1410
Gnomad4 ASJ exome
AF:
AC:
36
AN:
3134
Gnomad4 EAS exome
AF:
AC:
85
AN:
7636
Gnomad4 SAS exome
AF:
AC:
19
AN:
404
Gnomad4 FIN exome
AF:
AC:
1
AN:
40
Gnomad4 NFE exome
AF:
AC:
413
AN:
29822
Gnomad4 Remaining exome
AF:
AC:
64
AN:
4042
⚠️ The allele balance in gnomAD4 Exomes is highly skewed (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Heterozygous variant carriers
0
68
136
203
271
339
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00160 AC: 226AN: 141308Hom.: 2 Cov.: 32 AF XY: 0.00238 AC XY: 163AN XY: 68484 show subpopulations
GnomAD4 genome
AF:
AC:
226
AN:
141308
Hom.:
Cov.:
32
AF XY:
AC XY:
163
AN XY:
68484
Gnomad4 AFR
AF:
AC:
0.000466007
AN:
0.000466007
Gnomad4 AMR
AF:
AC:
0.000141503
AN:
0.000141503
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0.00060778
AN:
0.00060778
Gnomad4 SAS
AF:
AC:
0.0434881
AN:
0.0434881
Gnomad4 FIN
AF:
AC:
0.000233973
AN:
0.000233973
Gnomad4 NFE
AF:
AC:
0.0000933998
AN:
0.0000933998
Gnomad4 OTH
AF:
AC:
0.00104384
AN:
0.00104384
Heterozygous variant carriers
0
10
20
30
40
50
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at